OpenAlex
PricingAboutJobs
Log inGet started
Work

Idarucizumab: The Antidote for Reversal of Dabigatran

HTML

Year: 2015
Type: review
Source: Circulation
DOI: 10.1161/circulationaha.115.019628
Authors: John W. Eikelboom, Daniel J. Quinlan, Joanne van Ryn, Jeffrey I. Weitz
Institutions: Boehringer Ingelheim (Germany), King's College London, King's College Hospital, Thrombosis and Atherosclerosis Research Institute, McMaster University
Language: English

Topic: Acute Myocardial Infarction Research
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
SDG: Good health and well-being

Open Access status: closed

Funders: AstraZeneca, Canadian Institutes of Health Research
Award: Effect of HRG on Coagulation and Fibrinolysis
OpenAlex ID: W2196626069
FWCI: 4.929
Cites: 33
Cited by: 163
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms